February 15, 2018
Rose
The FDA announced yesterday that it will permit marketing of Viz.ai’s Contact, a clinical decision support (CDS) tool that analyzes CT results and highlights cases that may have experienced a stroke.
from MobiHealthNews http://ift.tt/2HgUDY4
February 15, 2018
Rose
MobiHealthNews
No comments
Related Posts:
How Phoenix Children’s uses iPads to deliver patient entertainment, education in one package- Artificial intelligence is getting the hype, now what are the applications?
- AI's potential runs up against lingering data issues
- UnitedHealthcare adds Apple Watch to Motion employee wellness program
- IT leaders highlight big success with machine learning models
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment